「fo」の検索結果
124件：51～55件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
almology. 2026;283:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
http://www.senju.co.jp/english/rd/thesis/ -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
ARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable lenses. It alleviates the impact of...
http://www.senju.co.jp/english/products/wettingsolution.html -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
444 Healthy Volunteers 1 SJP-0008 Japan Completed jRCT2031210280 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
http://www.senju.co.jp/english/rd/trial.html -
Business Activities | About Senju | SENJU Pharmaceutical
ering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses. Human innate instincts an...
http://www.senju.co.jp/english/about/business/ -
al Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuh...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf